Core Skills for Biotech Drug Development Hello, this is Hall T. Martin with the Startup Funding Espresso — your daily shot of startup funding and investing. Investors looking to invest in a biotech drug startup should diligence the team for key skills. Here are the key skills needed for biotech drug development: Knowledge of how to drug a target. This means identifying a molecule, often a protein, that is associated with the disease to be treated and could be treated by a drug. Ability to elucidate the mechanism of action. This is the process by which a drug functions to produce a pharmacological effect. Demonstrate safety and efficacy. This shows the therapeutic works and is non-toxic. Ability to design clinical trials to show safety and efficacy. This requires the ability to pick the right therapeutic indication and the appropriate patient population. Finally, understand the regulatory requirements for approval. This means identifying the right FDA path and the steps required to reach approval. Consider these skills in a founder before investing in a biotech drug startup. Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding. Let’s go startup something today. _______________________________________________________ For more episodes from Investor Connect, please visit the site at: http://investorconnect.org Check out our other podcasts here: https://investorconnect.org/ For Investors check out: https://tencapital.group/investor-landing/ For Startups check out: https://tencapital.group/company-landing/ For eGuides check out: https://tencapital.group/education/ For upcoming Events, check out https://tencapital.group/events/ For Feedback please contact info@tencapital.group Please follow, share, and leave a review. Music courtesy of Bensound.

Copyright (c) 2026, Hall Martin and investorconnect.org. All rights reserved.

Disclaimer:
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.